StreetAlpha
13F holdings · Q3 2026

Blue Owl Capital Holdings

New York, NY · files as Blue Owl Capital Holdings LP
Know the moment Blue Owl Capital Holdings filesYou follow Blue Owl Capital Holdings An email or push as soon as its next 13F reaches the SEC, with every stock it bought, sold and trimmed. Next 13F due by Feb 15, 2027
Holdings as of Sep 30, 2026Filed Nov 13, 2026Next filing due Feb 15, 2027CIK 1858703

Blue Owl Capital Holdings reported 73 stocks worth $546M in its 13F filing for Q3 2026, filed Nov 13, 2026. Its largest holdings are SPCX (25.5%), AKTS (11.9%) and LTGO (11.0%). Compared with Q2 2026, the fund opened new positions in LTGO, ETRA and OBX, added to AKTS, LRMR and AQST, trimmed SPCX, CGEM and SGMT and sold out of COF, EYPT and RYTM.

Latest filing: what Blue Owl Capital Holdings did in Q3 2026

vs Q2 2026
Filed 13F-HRView on SEC ↗
16 new7 added13 trimmed14 sold outBought about $156M · sold about $163M
New 16
See all 16 →
Added 7
See all 7 →
Trimmed 13
See all 13 →
Sold out 14
See all 14 →

Dollar changes use the share change at the quarter end price. New and sold out show the whole position.

Reported value$546M−17.0% vs last quarter
Stocks held7316 new · 14 sold out
Top 5 weight59.6%fairly concentrated
Turnover58%of the portfolio changed

Portfolio at a glance

share of reported value · Q3 2026
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 8 qtrsHeld
1
SPCX
Space Exploration Techn Corp Class A Com Stk
$139M25.5%923K−476K (−34%)2 of 8
2
AKTS
Aktis Oncology Inc
$65.1M11.9%3.3M+274K (+9%)3 of 8
3
LTGO
Latigo Biotherapeutics
$60.1M11.0%3.6MNew position1 of 8
4
LRMR
Larimar Therapeutics Inc
$31.7M5.8%9.9M+761K (+8%)8 of 8
5
ETRA
Electra Therapeutics Inc
$29.4M5.4%2.6MNew position1 of 8
6
NCDL
Nuveen Churchill Direct Lend Com SH
$24.1M4.4%2.1MNo change8 of 8
7
CGEM
Cullinan Therapeutics Inc
$21.5M3.9%1.4M−140K (−9%)8 of 8
8
OBDC
Blue Owl Capital Corporation
$21.5M3.9%2MNo change8 of 8
9
OBX
Obsidian Therapeutics Inc
$20.4M3.7%1.5MNew position1 of 8
10
SGMT
Sagimet Biosciences Inc
$11.1M2.0%1.1M−135K (−11%)8 of 8
🔒 63 more holdings in this filing. Create a free account or sign in to see them all.

Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.

Sold out

held in Q2 2026, gone in Q3 2026
StockValue last quarterShares sold
COF
Capital One Finl Corp
$24M120K
EYPT
Eyepoint Pharmaceuticals Inc
$10.9M763K
RYTM
Rhythm Pharmaceuticals Inc
$6.8M61K
CMPS
Compass Pathways PLC
$6.4M450K
RARE
Ultragenyx Pharmaceutical in
$6.1M183K

🔒 Free account: see all 14.

Options

valued at the underlying shares
StockTypeValueSharesChange
CMPS
Compass Pathways PLC
Call$888K800K−870,500
SGMT
Sagimet Biosciences Inc
Call$201K365K+365,400
VKTX
Viking Therapeutics Inc
Call$181K300K+300,000
ELDN
Eledon Pharmaceuticals Inc
Call$100K200K0
CMPX
Compass Therapeutics Inc
Call$49K620K+315,900

🔒 Free account: see all 6.

Reported value

last 8 quarters
$435MQ4 '24
$310MQ1 '25
$310MQ2 '25
$324MQ3 '25
$324MQ4 '25
$372MQ1 '26
$658MQ2 '26
$546MQ3 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q3 2026

straight from the SEC
FiledFormQuarter
Nov 13, 202613F-HRQ3 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

Blue Owl Capital Holdings 13F FAQ

What does Blue Owl Capital Holdings own?

Blue Owl Capital Holdings reported 73 stocks worth $546M in its 13F filing for Q3 2026, filed Nov 13, 2026. Its largest holdings are SPCX (25.5%), AKTS (11.9%) and LTGO (11.0%). The table above lists every position in the filing (the top 10 without an account).

What did Blue Owl Capital Holdings buy and sell in Q3 2026?

Compared with Q2 2026: 16 new positions, 7 added to, 13 trimmed and 14 sold out. New positions include LTGO, ETRA and OBX. It sold all of COF, EYPT and RYTM.

When will Blue Owl Capital Holdings file its next 13F?

Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.

How much is Blue Owl Capital Holdings's portfolio worth?

The Q3 2026 filing reports $546M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.